Literature DB >> 28987689

Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.

Christophe Cassinotto1, Anthony Dohan2, George Zogopoulos3, Laurence Chiche4, Christophe Laurent5, Antonio Sa-Cunha6, Adeline Cuggia7, Caroline Reinhold8, Benoît Gallix9.   

Abstract

BACKGROUND: Negative-margin status is a prognostic indicator for long-term survival following curative intent resection for pancreatic adenocarcinoma. Patients at increased risk for positive-margin resections may benefit from neoadjuvant chemotherapy prior to resection.
METHODS: We retrospectively analyzed preoperative computed-tomography (CT) scans in 108 consecutive patients that underwent curative intent resection for a resectable pancreatic ductal adenocarcinoma from 2009 to 2016 in two academic hospitals. Two radiologists independently staged the tumor, including tumor location, size, and tumor-to-superior mesenteric/portal vein (SMV/PV) contact. Uni and multivariate analysis were performed to identify independent predictors of an R1 resection.
RESULTS: Twenty-nine patients had an R1 resection (26.9%). Tumor size, location, and presence of tumor-to-SMV/PV contact were significantly associated with an R1 resection. In multivariate analysis, the independent parameters associated with resection status were: tumor size (R2=9.7), and tumor location (neck R2=6.6; pancreaticoduodenal interface R2=4.4; uncinate process R2=4.1), but not tumor-to-SMV/PV contact (R2=0.1, p=0.7). A simple CT score was built based on tumor size and location. Patients with an R0 resectability score ≥3, i.e. patients with tumor size ≥30mm (except when tumor location is at the pancreatico-duodenal interface) or patients with tumor size ≥20mm AND tumor located in the uncinate process or neck, were at high-risk of an R1 resection (AUC, 0.82; sensitivity, 79%; specificity, 76%). This score also showed good diagnostic performances for predicting an R1 resection involving the medial resection margin only (AUC, 0.85).
CONCLUSIONS: A simple score based on tumor location and size can accurately predict patients at high-risk of an R1 resection.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CT scan; Cancer staging; Pancreatic adenocarcinoma; Prognosis; Resection status

Mesh:

Year:  2017        PMID: 28987689     DOI: 10.1016/j.ejrad.2017.06.028

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Predicting Positive Margins in Pancreatic Head Adenocarcinoma After Neoadjuvant Therapy: Investigating Disparities in Quality Care Using the National Cancer Database.

Authors:  Corey Suraci; Katelyn Young; James Dove; Mohsen Shabahang; Joseph Blansfield
Journal:  Ann Surg Oncol       Date:  2020-08-27       Impact factor: 5.344

2.  Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.

Authors:  Amir A Borhani; Rohit Dewan; Alessandro Furlan; Natalie Seiser; Amer H Zureikat; Aatur D Singhi; Brian Boone; Nathan Bahary; Melissa E Hogg; Michael Lotze; Herbert J Zeh; Mitchell E Tublin
Journal:  AJR Am J Roentgenol       Date:  2019-12-04       Impact factor: 3.959

Review 3.  Radiomics in hepatocellular carcinoma: a quantitative review.

Authors:  Taiga Wakabayashi; Farid Ouhmich; Cristians Gonzalez-Cabrera; Emanuele Felli; Antonio Saviano; Vincent Agnus; Peter Savadjiev; Thomas F Baumert; Patrick Pessaux; Jacques Marescaux; Benoit Gallix
Journal:  Hepatol Int       Date:  2019-08-31       Impact factor: 9.029

4.  Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery.

Authors:  Shannan M Dickinson; Caitlin A McIntyre; Juliana B Schilsky; Kate A Harrington; Scott R Gerst; Jessica R Flynn; Mithat Gonen; Marinela Capanu; Winston Wong; Sharon Lawrence; Peter J Allen; Eileen M O'Reilly; William R Jarnagin; Michael I D'Angelica; Vinod P Balachandran; Jeffrey A Drebin; T Peter Kingham; Amber L Simpson; Richard K Do
Journal:  Abdom Radiol (NY)       Date:  2020-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.